Stay updated with breaking news from Avisi Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO — Surgeons should optimize their treatment of dysphotopsias based on each patient’s natural ability for neuroadaptation, according to a speaker here.
Take note of these November and December announcements, including a $65 Series A for Penn gene-editing spinout iECURE. Plus, the Center for Diagnostics Discovery is launching in Horsham.